Table 3.
Disease status | No. | CR | PR | Response rate (%) | 95% CI |
---|---|---|---|---|---|
Rituximab naïve | 3 | 1 | 1 | 66.7 | 9.4-99.2 |
Rituximab sensitive | 19 | 3 | 7 | 52.6 | 28.9-75.6 |
Rituximab refractory | 18 | 1 | 2 | 16.7 | 3.6-41.4 |
Chemotherapy sensitive* | 26 | 4 | 7 | 42.3 | 23.4-63.1 |
Chemotherapy refractory* | 14 | 1 | 3 | 28.6 | 8.4-58.1 |
On the basis of response to most recent prior chemotherapy.